» Authors » J E Hoogendijk

J E Hoogendijk

Explore the profile of J E Hoogendijk including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 44
Citations 910
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
van de Vlekkert J, Hoogendijk J, de Visser M
Neuromuscul Disord . 2015 Mar; 25(6):451-6. PMID: 25817837
The objective of this study was to investigate if patients with endomysial mononuclear cell infiltrates invading non-necrotic fibers have a disease course consistent with inclusion body myositis (IBM), irrespective of...
2.
van Spaendonck-Zwarts K, van der Kooi A, van den Berg M, Ippel E, Boven L, Yee W, et al.
Neth Heart J . 2012 Jan; 20(5):219-28. PMID: 22215463
Background: Desmin-related myopathy (DRM) is an autosomally inherited skeletal and cardiac myopathy, mainly caused by dominant mutations in the desmin gene (DES). We describe new families carrying the p.S13F or...
3.
van de Vlekkert J, Hoogendijk J, de Haan R, Algra A, van der Tweel I, van der Pol W, et al.
Neuromuscul Disord . 2010 Apr; 20(6):382-9. PMID: 20423755
To determine if high-dose pulsed dexamethasone is more effective and safer than daily high-dose prednisolone in treatment-naive adult patients with inflammatory myopathies (sporadic inclusion body myositis excluded) we performed a...
4.
Blok M, van den Bosch B, Jongen E, Hendrickx A, de Die-Smulders C, Hoogendijk J, et al.
J Med Genet . 2009 Jul; 46(11):776-85. PMID: 19578034
Background: Mutations in the DNA polymerase-gamma (POLG) gene are a major cause of clinically heterogeneous mitochondrial diseases, associated with mtDNA depletion and multiple deletions. Objective: To determine the spectrum of...
5.
Bronner I, Hoogendijk J, de Visser M, van de Vlekkert J, Badrising U, Wintzen A, et al.
Tissue Antigens . 2009 Jun; 73(6):586-9. PMID: 19493236
Leukocytes are involved in the pathogenesis of idiopathic inflammatory myopathies (IIMs). Immunoglobulin G (IgG) receptors (FcgammaR) link the specificity of IgG to the effector functions of leukocytes. Several FcgammaR subclasses...
6.
van de Vlekkert J, Hoogendijk J, Frijns C, de Visser M
J Neurol Neurosurg Psychiatry . 2008 May; 79(6):729-30. PMID: 18487558
Dermatomyositis (DM), polymyositis and unspecified myositis are idiopathic inflammatory myopathies in which prednisone is usually started as soon as the diagnosis has been established. Therefore, little is known about the...
7.
Spruijt L, Hoogendijk J, Hendrickx A, de Coo I, Doevendans P, de Jong P, et al.
Am J Med Genet A . 2006 Jun; 140(13):1478-81. PMID: 16770803
No abstract available.
8.
Bronner I, van der Meulen M, de Visser M, Kalmijn S, van Venrooij W, Voskuyl A, et al.
Ann Rheum Dis . 2006 Apr; 65(11):1456-61. PMID: 16606652
Background: Although polymyositis and dermatomyositis are regarded as treatable disorders, prognosis is not well known, as in the literature long-term outcome and prognostic factors vary widely. Aim: To analyse the...
9.
Bienfait H, Faber C, Baas F, Gabreels-Festen A, Koelman J, Hoogendijk J, et al.
J Neurol Neurosurg Psychiatry . 2006 Mar; 77(4):534-7. PMID: 16543539
A late onset axonal Charcot-Marie-Tooth phenotype is described, resulting from a novel mutation in the myelin protein zero (MPZ) gene. Comparative computer modelling of the three dimensional structure of the...
10.
Hoogendijk J, Bijlsma J, van Engelen B, Lindeman E, van Royen-Kerkhof A, de Rie M, et al.
Ned Tijdschr Geneeskd . 2005 Oct; 149(38):2104-11. PMID: 16201600
This guideline presents recommendations for the diagnosis and treatment of dermatomyositis, polymyositis and sporadic inclusion body myositis (sIBM) according to the best available evidence. Characteristic skin abnormalities can be sufficient...